-
Je něco špatně v tomto záznamu ?
Vitamin D upregulates endothelin-1, ETBR, eNOS mRNA expression and attenuates vascular remodelling and ischemia in kidney fibrosis model in mice
N. Arfian, M. H. Kusuma, N. Anggorowati, D. B. Nugroho, A. Jeffilano, Y. Suzuki, K. Ikeda, N. Emoto
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- endoteliální buňky pupečníkové žíly (lidské) MeSH
- endotelin-1 biosyntéza MeSH
- fibróza MeSH
- ischemie farmakoterapie metabolismus MeSH
- lidé MeSH
- messenger RNA biosyntéza MeSH
- myši MeSH
- nemoci ledvin farmakoterapie metabolismus MeSH
- receptor endotelinu B biosyntéza MeSH
- remodelace cév účinky léků fyziologie MeSH
- synthasa oxidu dusnatého, typ III biosyntéza MeSH
- upregulace účinky léků fyziologie MeSH
- vitamin D farmakologie terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
We examined the upregulation of ET-1/ETBR/eNOS signaling in renoprotective effect of vitamin D in kidney fibrosis model in mice using unilateral ureteral obstruction (UUO). One group was treated with intraperitoneal injection of 0.125 mg/kg of Calcitriol (UUO+VD). Vascular remodeling was quantified based on lumen area and lumen/wall area ratio (LWAR) of intrarenal arteries using Sirius Red staining. ET-1, ETBR, eNOS, CD31 and VEGF mRNA expressions were quantified using qRT-PCR. Focusing on endothelin-1 (ET-1) signaling in endothelial cells (EC), siRNA of ET-1 was performed in human umbilical vein endothelial cells (HUVEC) for reducing ET-1 expression. Then HUVECs were treated with and without 100 nM Calcitriol treatment in hypoxic and normoxic conditions to elucidate ET-1/eNOS signaling. Our in vivo study revealed vascular remodeling and renal ischemia attenuation after Calcitriol treatment. Vascular remodeling was attenuated in the UUO+VD group as shown by increasing lumen areas and LWAR in intrarenal arteries. These findings were associated with significant higher CD31 and VEGF mRNA expression compared to the UUO group. Vitamin D treatment also increased ET-1, ETBR and eNOS mRNA expressions. Our in vitro study demonstrated Calcitriol induced ET-1 and eNOS mRNA expressions upregulation in HUVEC under normoxic and hypoxic condition. Meanwhile, siRNA for ET-1 inhibited the upregulation of eNOS mRNA expression after Calcitriol treatment. Vitamin D ameliorates kidney fibrosis through attenuating vascular remodeling and ischemia with upregulating ET-1/ETBR and eNOS expression.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19005332
- 003
- CZ-PrNML
- 005
- 20210531150634.0
- 007
- ta
- 008
- 190204s2018 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933823 $2 doi
- 035 __
- $a (PubMed)29947534
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Arfian, N. $u Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas GadjahMada, Yogyakarta, Indonesia
- 245 10
- $a Vitamin D upregulates endothelin-1, ETBR, eNOS mRNA expression and attenuates vascular remodelling and ischemia in kidney fibrosis model in mice / $c N. Arfian, M. H. Kusuma, N. Anggorowati, D. B. Nugroho, A. Jeffilano, Y. Suzuki, K. Ikeda, N. Emoto
- 520 9_
- $a We examined the upregulation of ET-1/ETBR/eNOS signaling in renoprotective effect of vitamin D in kidney fibrosis model in mice using unilateral ureteral obstruction (UUO). One group was treated with intraperitoneal injection of 0.125 mg/kg of Calcitriol (UUO+VD). Vascular remodeling was quantified based on lumen area and lumen/wall area ratio (LWAR) of intrarenal arteries using Sirius Red staining. ET-1, ETBR, eNOS, CD31 and VEGF mRNA expressions were quantified using qRT-PCR. Focusing on endothelin-1 (ET-1) signaling in endothelial cells (EC), siRNA of ET-1 was performed in human umbilical vein endothelial cells (HUVEC) for reducing ET-1 expression. Then HUVECs were treated with and without 100 nM Calcitriol treatment in hypoxic and normoxic conditions to elucidate ET-1/eNOS signaling. Our in vivo study revealed vascular remodeling and renal ischemia attenuation after Calcitriol treatment. Vascular remodeling was attenuated in the UUO+VD group as shown by increasing lumen areas and LWAR in intrarenal arteries. These findings were associated with significant higher CD31 and VEGF mRNA expression compared to the UUO group. Vitamin D treatment also increased ET-1, ETBR and eNOS mRNA expressions. Our in vitro study demonstrated Calcitriol induced ET-1 and eNOS mRNA expressions upregulation in HUVEC under normoxic and hypoxic condition. Meanwhile, siRNA for ET-1 inhibited the upregulation of eNOS mRNA expression after Calcitriol treatment. Vitamin D ameliorates kidney fibrosis through attenuating vascular remodeling and ischemia with upregulating ET-1/ETBR and eNOS expression.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a endotelin-1 $x biosyntéza $7 D019332
- 650 _2
- $a fibróza $7 D005355
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ischemie $x farmakoterapie $x metabolismus $7 D007511
- 650 _2
- $a nemoci ledvin $x farmakoterapie $x metabolismus $7 D007674
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a synthasa oxidu dusnatého, typ III $x biosyntéza $7 D052250
- 650 _2
- $a messenger RNA $x biosyntéza $7 D012333
- 650 _2
- $a receptor endotelinu B $x biosyntéza $7 D044023
- 650 _2
- $a upregulace $x účinky léků $x fyziologie $7 D015854
- 650 _2
- $a remodelace cév $x účinky léků $x fyziologie $7 D066253
- 650 _2
- $a vitamin D $x farmakologie $x terapeutické užití $7 D014807
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kusuma, M Hh. $u Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas GadjahMada, Yogyakarta, Indonesia
- 700 1_
- $a Anggorowati, N. $u Department of Anatomical Pathology, Faculty of Medicine, PublicHealth and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
- 700 1_
- $a Nugroho, D. B. $u Department of Clinical Pharmacy, Kobe Pharmaceutical University, Kobe, Japan
- 700 1_
- $a Jeffilano, A. $u Department of Clinical Pharmacy, Kobe Pharmaceutical University, Kobe, Japan
- 700 1_
- $a Suzuki, Y. $u Department of Clinical Pharmacy, Kobe Pharmaceutical University, Kobe, Japan; Division of Cardiovascular Medicine,Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
- 700 1_
- $a Ikeda, K. $u Department of Clinical Pharmacy, Kobe Pharmaceutical University, Kobe, Japan
- 700 1_
- $a Emoto, N. $u Department of Clinical Pharmacy, Kobe Pharmaceutical University, Kobe, Japan; Division of Cardiovascular Medicine,Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 1 (2018), s. S137-S147
- 773 0_
- $t ET-15 $g (2018), s. S137-S147 $w MED00206979
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29947534 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20190204 $b ABA008
- 991 __
- $a 20210531150633 $b ABA008
- 999 __
- $a ok $b bmc $g 1376295 $s 1043537
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c Suppl. 1 $d S137-S147 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2018 $d S137-S147 $m ET-15 $x MED00206979
- LZP __
- $b NLK118 $a Pubmed-20190204
